Background. We found previously that the clinical advantages of living dono
r (LD) renal transplantation lead to financial cost savings compared to eit
her cadaveric donation (CAD) or dialysis. Here, we analyze the sources of t
he cost savings of LD versus CAD kidney transplantation.
Methods. We used United States Renal Data System data to merge United Netwo
rk for Organ Sharing registry information with Medicare claims data for 199
1-1996, Information was available for 42,868 CAD and 13,754 LD transplants.
More than 5 million Medicare payment records were analyzed. We calculated
the difference in average payments made by Medicare for CAD and LD for serv
ices provided during the first posttransplant year.
Results. Average total payments were $39,534 and $24,652 for CAD and LD, re
spectively (P<0.0001) during the first posttransplant year. The largest sou
rce of the difference in payments was in inpatient hospitals, representing
$10,653.67 (P<0.0001). For patients who had Medicare as the primary payer,
average transplant charges were significantly higher for CAD donation ($79,
730 vs. $69,547, P<0.0001); average transplant payments demonstrated no sta
tistical differences ($28,483 vs. $28,447, P=0.858). Therefore, inferred pr
ofitability was significantly higher for LD,
Conclusions. Medicare payments are remarkably lower for LD compared to CAD
in every category. The single largest cost saving comes from inpatient hosp
ital services. A portion of the savings from LD could be invested in progra
ms to expand living kidney donation.